|
|
|
Stress IncontinenceThe ability to hold urine and control urination depends on the normal function of the lower urinary tract,
the kidneys, and the nervous system. You must also have the ability to recognize and respond to the urge to urinate.
Stress urinary incontinence is the most common type of urinary incontinence in women.
Risk factors for stress incontinence include:
Symptoms Involuntary loss of urine is the main symptom. It may occur when:
Tests and exams:
In some women, a pelvic examination may reveal that the bladder or urethra is bulging into the vaginal space. Tests may include:
The health care provider may also measure the change in the angle of the urethra when at rest and when straining (Q-tip test). An angle change of greater than 30 degrees often means there is significant weakness of the muscles and tissues that support the bladder. Treatment
There are four major categories of treatment for stress incontinence:
Behavioral changes involve decreasing how many fluids you drink,
if you drink too much during the day. (You should not decrease your fluid intake
if you drink normal amounts of fluids.)
Medications Used for Stress Incontinence Alpha-Adrenergic Agonists. Alpha-adrenergic agonists, such as clonidine (Catapres), are used to strengthen the smooth muscle that opens and closes the internal sphincter. These drugs include ephedrine and pseudoephedrine, which have been common ingredients in numerous over-the-counter decongestants and appetite suppressants. Such drugs may be helpful for select patients with mild stress incontinence not caused by nerve damage, but evidence on their benefits is weak. They also can have significant side effects, including agitation, insomnia, and anxiety. Alpha-adrenergic agonists may have adverse effects on the heart in people with existing heart problems. People with glaucoma, diabetes, hyperthyroidism, heart disease, or high blood pressure should not take these drugs. Antidepressants Evidence indicates that both urge and stress incontinence are affected, in part, by central nervous system processes. Investigators are particularly interested in serotonin, norepinephrine, and noradrenaline, which are chemical messengers (called neurotransmitters) that affect pathways involved with urination. (These neurotransmitters are also important for many other emotional and physical functions.) Antidepressants targeting one or both of these neurotransmitters are sometimes used for urge incontinence and may also be helpful for some people with stress incontinence. Tricyclic Antidepressants. Tricyclic antidepressants, such as imipramine (Tofranil), may help both urge and stress incontinence. They act as anticholinergic drugs and relax the bladder. They also strengthen the internal sphincter. These drugs should be used carefully. They pose some risk for adverse effects on the heart and possibly the lungs, and they have other severe side effects in older adults. These antidepressants produce side effects similar to anticholinergic drugs, and may cause drowsiness. They may also cause overflow incontinence in some people. Estrogen vaginal therapy (preferably with estriol vaginal crème or suppositories) can be used to improve urinary frequency, urgency, and burning in postmenopausal women. It also can improve the tone and blood supply of the urethral sphincter muscles. Surgical treatment is only recommended after the exact cause of the urinary incontinence has been determined. |
|
|
Stress Incontinence
Understanding Stress Incontinence
|
|
|||||
|
|
|||||
|
|

